Intana Bioscience delivers biologically relevant target engagement data that enables smarter clinical decisions, improved candidate selection, and reduced translational risk.
Conventional assays often rely on artificial systems that fail to capture physiological reality. Intana uses proprietary technology to measure target occupancy directly on endogenous proteins in presence of all known and unknown competing ligands.
Native target concentrations instead of overexpression systems provide more predictive translational data.
Prioritize molecules that truly reach and engage targets at clinically feasible doses.
Detect insufficient target engagement before entering expensive clinical studies.
Successful therapeutics do not only bind targets. They must reach the right tissue, achieve sufficient local exposure, and engage the endogenous target under physiological conditions.
Your active ingredient becomes part of a ligand network whose concentrations influence each other. Knowing true occupancy data establishes a direct link between exposure and pharmacological activity and allows for a better understanding of clinical efficacy.
Intana Bioscience supports biotech and pharmaceutical companies with precise target engagement and occupancy analytics.